Senate Health Committee To Hold Hearing On Generic Drug Access Jan. 28

January 21, 2016 at 2:21 PM
FDA drug center chief Janet Woodcock will testify at a Senate health committee hearing Jan. 28 on whether the generic drug user fee law has provided the overhaul necessary to ensure patients have expeditious access to generic drugs. This will be the committee's first hearing on generic drug user fees this Congress, according to a release from the committee. The hearing comes after House oversight committee Republicans asked FDA for a trove of documents in a bid to determine whether...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.